Resultats de la cerca - Erho, Nicholas
- Mostrar 1 - 20 resultats de 42
- Anar a la pàgina següent
-
1
Transcriptome-Wide Detection of Differentially Expressed Coding and Non-Coding Transcripts and Their Clinical Significance in Prostate Cancer per Erho, Nicholas, Buerki, Christine, Triche, Timothy J., Davicioni, Elai, Vergara, Ismael A.
Publicat 2012Text -
2
-
3
Development of a predictive model for stromal content in prostate cancer samples to improve signature performance per Boufaied, Nadia, Takhar, Mandeep, Nash, Claire, Erho, Nicholas, Bismar, Tarek A, Davicioni, Elai, Thomson, Axel A
Publicat 2019Text -
4
Genomic “Dark Matter” in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers per Vergara, Ismael A., Erho, Nicholas, Triche, Timothy J., Ghadessi, Mercedeh, Crisan, Anamaria, Sierocinski, Thomas, Black, Peter C., Buerki, Christine, Davicioni, Elai
Publicat 2012Text -
5
Prostate cancer radiomics and the promise of radiogenomics per Stoyanova, Radka, Takhar, Mandeep, Tschudi, Yohann, Ford, John C., Solórzano, Gabriel, Erho, Nicholas, Balagurunathan, Yoganand, Punnen, Sanoj, Davicioni, Elai, Gillies, Robert J., Pollack, Alan
Publicat 2016Text -
6
Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location per Faisal, Farzana A., Sundi, Debasish, Tosoian, Jeffrey J., Choeurng, Voleak, Alshalalfa, Mohammed, Ross, Ashley E., Klein, Eric, Den, Robert, Dicker, Adam, Erho, Nicholas, Davicioni, Elai, Lotan, Tamara L., Schaeffer, Edward M.
Publicat 2015Text -
7
Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features per Karnes, Robert Jeffrey, Choeurng, Voleak, Ross, Ashley E., Schaeffer, Edward M., Klein, Eric A., Freedland, Stephen J., Erho, Nicholas, Yousefi, Kasra, Takhar, Mandeep, Davicioni, Elai, Cooperberg, Matthew R., Trock, Bruce J.
Publicat 2017Text -
8
Evaluation of a 24-Gene Signature for Prognosis of Metastatic Events and Prostate Cancer-Specific Mortality per Pellegrini, Kathryn L., Sanda, Martin G., Patil, Dattatraya, Long, Qi, Santiago-Jiménez, María, Takhar, Mandeep, Erho, Nicholas, Yousefi, Kasra, Davicioni, Elai, Klein, Eric A., Jenkins, Robert B., Karnes, R. Jeffrey, Moreno, Carlos S.
Publicat 2017Text -
9
Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer per Mitra, Anirban P., Lam, Lucia L., Ghadessi, Mercedeh, Erho, Nicholas, Vergara, Ismael A., Alshalalfa, Mohammed, Buerki, Christine, Haddad, Zaid, Sierocinski, Thomas, Triche, Timothy J., Skinner, Eila C., Davicioni, Elai, Daneshmand, Siamak, Black, Peter C.
Publicat 2014Text -
10
Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1 per Spans, Lien, Van den Broeck, Thomas, Smeets, Elien, Prekovic, Stefan, Thienpont, Bernard, Lambrechts, Diether, Karnes, R. Jeffrey, Erho, Nicholas, Alshalalfa, Mohammed, Davicioni, Elai, Helsen, Christine, Gevaert, Thomas, Tosco, Lorenzo, Haustermans, Karin, Lerut, Evelyne, Joniau, Steven, Claessens, Frank
Publicat 2016Text -
11
SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy Cohort per Johnson, Michael H., Ross, Ashley E., Alshalalfa, Mohammed, Erho, Nicholas, Yousefi, Kasra, Glavaris, Stephanie, Fedor, Helen, Han, Misop, Faraj, Sheila F., Bezerra, Stephania M., Netto, George, Partin, Alan W., Trock, Bruce J., Davicioni, Elai, Schaeffert, Edward M.
Publicat 2016Text -
12
Metabolomic profiling identifies biochemical pathways associated with castrate resistant prostate cancer per Kaushik, Akash K, Vareed, Shaiju K, Basu, Sumanta, Putluri, Vasanta, Putluri, Nagireddy, Panzitt, Katrin, Brennan, Christine A, Chinnaiyan, Arul M, Vergara, Ismael A., Erho, Nicholas, Weigel, Nancy L, Mitsiades, Nicholas, Shojaie, Ali, Palapattu, Ganesh, Michailidis, George, Sreekumar, Arun
Publicat 2013Text -
13
Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens per Knudsen, Beatrice S., Kim, Hyung L., Erho, Nicholas, Shin, Heesun, Alshalalfa, Mohammed, Lam, Lucia L.C., Tenggara, Imelda, Chadwich, Karen, Van Der Kwast, Theo, Fleshner, Neil, Davicioni, Elai, Carroll, Peter R., Cooperberg, Matthew R., Chan, June M., Simko, Jeffry P.
Publicat 2016Text -
14
Integrated classification of prostate cancer reveals a novel luminal subtype with poor outcome per You, Sungyong, Knudsen, Beatrice S, Erho, Nicholas, Alshalalfa, Mohammed, Takhar, Mandeep, Ashab, Hussam Al-deen, Davicioni, Elai, Karnes, R Jeffrey, Klein, Eric A, Den, Robert B, Ross, Ashley E, Schaeffer, Edward M, Garraway, Isla P, Kim, Jayoung, Freeman, Michael R
Publicat 2016Text -
15
Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma per Alshalalfa, Mohammed, Liu, Yang, Wyatt, Alexander W., Gibb, Ewan A., Tsai, Harrison K., Erho, Nicholas, Lehrer, Jonathan, Takhar, Mandeep, Ramnarine, Varune R., Collins, Colin C., Den, Robert B., Schaeffer, Edward M., Davicioni, Elai, Lotan, Tamara L., Bismar, Tarek A.
Publicat 2019Text -
16
Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay per Torres, Alba, Alshalalfa, Mohammed, Tomlins, Scott A., Erho, Nicholas, Gibb, Ewan A., Chelliserry, Jijumon, Lim, Lony, Lam, Lucia L.C., Faraj, Sheila F., Bezerra, Stephania M., Davicioni, Elai, Yousefi, Kasra, Ross, Ashley E., Netto, George J., Schaeffer, Edward M., Lotan, Tamara L.
Publicat 2017Text -
17
Tristetraprolin Is a Prognostic Biomarker for Poor Outcomes among Patients with Low-Grade Prostate Cancer per Rounbehler, Robert J., Berglund, Anders E., Gerke, Travis, Takhar, Mandeep M., Awasthi, Shivanshu, Li, Weimin, Davicioni, Elai, Erho, Nicholas G., Ross, Ashley E., Schaeffer, Edward M., Klein, Eric A., Karnes, R. Jeffrey, Jenkins, Robert B., Cleveland, John L., Park, Jong Y., Yamoah, Kosj
Publicat 2018Text -
18
Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome per Hurley, Paula J., Marchionni, Luigi, Simons, Brian W., Ross, Ashley E., Peskoe, Sarah B., Miller, Rebecca M., Erho, Nicholas, Vergara, Ismael A., Ghadessi, Mercedeh, Huang, Zhenhua, Gurel, Bora, Park, Ben Ho, Davicioni, Elai, Jenkins, Robert B., Platz, Elizabeth A., Berman, David M., Schaeffer, Edward M.
Publicat 2012Text -
19
Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy per Erho, Nicholas, Crisan, Anamaria, Vergara, Ismael A., Mitra, Anirban P., Ghadessi, Mercedeh, Buerki, Christine, Bergstralh, Eric J., Kollmeyer, Thomas, Fink, Stephanie, Haddad, Zaid, Zimmermann, Benedikt, Sierocinski, Thomas, Ballman, Karla V., Triche, Timothy J., Black, Peter C., Karnes, R. Jeffrey, Klee, George, Davicioni, Elai, Jenkins, Robert B.
Publicat 2013Text -
20
Characterization of 1,577 Primary Prostate Cancers Reveals Novel Biological and Clinicopathological Insights into Molecular Subtypes per Tomlins, Scott A., Alshalalfa, Mohammed, Davicioni, Elai, Erho, Nicholas, Yousefi, Kasra, Zhao, Shuang, Haddad, Zaid, Den, Robert B., Dicker, Adam P., Trock, Bruce, DeMarzo, Angelo, Ross, Ashley, Schaeffer, Edward M., Klein, Eric A., Magi-Galluzzi, Cristina, Karnes, Jeffery R., Jenkins, Robert B., Feng, Felix Y.
Publicat 2015Text